GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SLS BIO Co Ltd (XKRX:246250) » Definitions » EV-to-Revenue

SLS BIO Co (XKRX:246250) EV-to-Revenue : 4.48 (As of May. 25, 2024)


View and export this data going back to 2016. Start your Free Trial

What is SLS BIO Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, SLS BIO Co's enterprise value is ₩29,802 Mil. SLS BIO Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩6,655 Mil. Therefore, SLS BIO Co's EV-to-Revenue for today is 4.48.

The historical rank and industry rank for SLS BIO Co's EV-to-Revenue or its related term are showing as below:

XKRX:246250' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.63   Med: 4.25   Max: 7.97
Current: 4.48

During the past 9 years, the highest EV-to-Revenue of SLS BIO Co was 7.97. The lowest was 3.63. And the median was 4.25.

XKRX:246250's EV-to-Revenue is ranked worse than
62.78% of 223 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.23 vs XKRX:246250: 4.48

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-25), SLS BIO Co's stock price is ₩4810.00. SLS BIO Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩897.09. Therefore, SLS BIO Co's PS Ratio for today is 5.36.


SLS BIO Co EV-to-Revenue Historical Data

The historical data trend for SLS BIO Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SLS BIO Co EV-to-Revenue Chart

SLS BIO Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only 7.63 9.40 7.85 3.17 3.58

SLS BIO Co Quarterly Data
Sep22 Dec22 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial 3.17 - - 3.58 5.88

Competitive Comparison of SLS BIO Co's EV-to-Revenue

For the Diagnostics & Research subindustry, SLS BIO Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SLS BIO Co's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SLS BIO Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where SLS BIO Co's EV-to-Revenue falls into.



SLS BIO Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

SLS BIO Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=29801.523/6655.039
=4.48

SLS BIO Co's current Enterprise Value is ₩29,802 Mil.
SLS BIO Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩6,655 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SLS BIO Co  (XKRX:246250) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

SLS BIO Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=4810.00/897.091
=5.36

SLS BIO Co's share price for today is ₩4810.00.
SLS BIO Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩897.09.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SLS BIO Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of SLS BIO Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


SLS BIO Co (XKRX:246250) Business Description

Traded in Other Exchanges
N/A
Address
Gwanggyo Central Biz Tower, 7th floor, Changryong-dong 260, Gyeonggi-do, Suwon-si, KOR, 16229
SLS BIO Co Ltd is engaged in providing drug development supporting services and pharmaceutical product QC through general tests and assays and instrumental analysis.

SLS BIO Co (XKRX:246250) Headlines

No Headlines